+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Opioid-Induced Constipation (OIC) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768109
  • Report
  • 105 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Alkermes Plc
  • Astorg Partners
  • AstraZeneca Plc
  • IQVIA Holdings Inc
  • Merck & Co Inc
  • Shionogi & Co Ltd
  • MORE
The global clinical trial report- “2019 Opioid-Induced Constipation (OIC) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Opioid-Induced Constipation (OIC). It presents in-depth analysis of Opioid-Induced Constipation (OIC) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Opioid-Induced Constipation (OIC).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Opioid-Induced Constipation (OIC) clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Opioid-Induced Constipation (OIC)

The research work is prepared through extensive and continuous research on Opioid-Induced Constipation (OIC) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Opioid-Induced Constipation (OIC) patients are identified
  • The report includes panorama of Opioid-Induced Constipation (OIC) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Opioid-Induced Constipation (OIC) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alkermes Plc
  • Astorg Partners
  • AstraZeneca Plc
  • IQVIA Holdings Inc
  • Merck & Co Inc
  • Shionogi & Co Ltd
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Opioid-Induced Constipation (OIC) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Opioid-Induced Constipation (OIC) Clinical Trials by Region
2.2.2 Average Enrollment of Opioid-Induced Constipation (OIC) Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Opioid-Induced Constipation (OIC) Treatment, 2019

3. Region wise Opioid-Induced Constipation (OIC) Clinical Trials
3.1 Asia Pacific Opioid-Induced Constipation (OIC) Clinical Trials by Country
3.2 Europe Opioid-Induced Constipation (OIC) Clinical Trials by Country
3.3 North America Opioid-Induced Constipation (OIC) Clinical Trials by Country
3.4 Middle East and Africa Opioid-Induced Constipation (OIC) Clinical Trials by Country
3.5 South and Central America Opioid-Induced Constipation (OIC) Clinical Trials by Country

4. Opioid-Induced Constipation (OIC) Clinical Trial Trends
4.1 Start Year wise Opioid-Induced Constipation (OIC) Clinical Trials
4.2 Phase wise Opioid-Induced Constipation (OIC) Clinical Trials
4.3 Trial Status wise Opioid-Induced Constipation (OIC) Clinical Trials
4.4 Trial Type wise Opioid-Induced Constipation (OIC) Clinical Trials

5. Opioid-Induced Constipation (OIC) Average Enrollment Trends
5.1 Average Enrollment in Opioid-Induced Constipation (OIC) Trials by Year
5.2 Average Enrollment in Opioid-Induced Constipation (OIC) Trials by Phase
5.3 Average Enrollment in Opioid-Induced Constipation (OIC) Trials by Status
5.4 Average Enrollment in Opioid-Induced Constipation (OIC) Trials by Type of Trial

6. Companies Participating in Opioid-Induced Constipation (OIC) Clinical Trials
6.1 Opioid-Induced Constipation (OIC) Trials by Sponsor Type
6.2 Opioid-Induced Constipation (OIC) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Opioid-Induced Constipation (OIC) Trials- Phase 1
7.2 Opioid-Induced Constipation (OIC) Trials- Phase 2
7.3 Opioid-Induced Constipation (OIC) Trials- Phase 3
7.4 Opioid-Induced Constipation (OIC) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Opioid-Induced Constipation (OIC) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Opioid-Induced Constipation (OIC) Clinical Trials and Enrolment
Figure 5: Europe - Country wise Opioid-Induced Constipation (OIC) Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Opioid-Induced Constipation (OIC) Clinical Trials and Enrolment
Figure 7: North America - Country wise Opioid-Induced Constipation (OIC) Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Opioid-Induced Constipation (OIC) Clinical Trials and Enrolment
Figure 9: Opioid-Induced Constipation (OIC) Clinical Trials by Phase
Figure 10: Opioid-Induced Constipation (OIC) Clinical Trials by Trial Status
Figure 11: Opioid-Induced Constipation (OIC) Clinical Trials by Type
Figure 12: Opioid-Induced Constipation (OIC) Clinical Trials by Sponsor Type
Figure 13: Opioid-Induced Constipation (OIC) Clinical Trials by Leading Sponsors
Figure 14: Opioid-Induced Constipation (OIC) Average Enrollment by Phase
Figure 15: Opioid-Induced Constipation (OIC) Average Enrollment by Trial Status
Figure 16: Opioid-Induced Constipation (OIC) Average Enrollment by Type
Figure 17: Opioid-Induced Constipation (OIC)- Average Enrolment by Type of Sponsors
Figure 18: Opioid-Induced Constipation (OIC)- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Opioid-Induced Constipation (OIC) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Opioid-Induced Constipation (OIC) Clinical Trials and Enrolment
Table 5: Europe - Country wise Opioid-Induced Constipation (OIC) Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Opioid-Induced Constipation (OIC) Clinical Trials and Enrolment
Table 7: North America - Country wise Opioid-Induced Constipation (OIC) Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Opioid-Induced Constipation (OIC) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Opioid-Induced Constipation (OIC) Average Enrollment by Phase
Table 15: Opioid-Induced Constipation (OIC) Average Enrollment by Trial Status
Table 16: Opioid-Induced Constipation (OIC) Average Enrollment by Type
Table 17: Opioid-Induced Constipation (OIC)- Average Enrolment by Type of Sponsors
Table 18: Opioid-Induced Constipation (OIC)- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Alkermes Plc
  • Astorg Partners
  • AstraZeneca Plc
  • IQVIA Holdings Inc
  • Merck & Co Inc
  • Mundipharma International Ltd
  • Progenics Pharmaceuticals Inc
  • Shionogi & Co Ltd
  • Theravance Biopharma Inc
  • Valeant Pharmaceuticals International Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4768109
Adroll
adroll